2021 ASCO Virtual Direct™ Highlights


 

2021 ASCO Summary of mNSCLC Trials: IO Efficacy & irAEs, Racial Disparities in Biomarker & Clinical Trial Enrollment, Amivantamab for EGFR-Resistance

15 views
August 20, 2021
Comments 0
Login to view comments. Click here to Login